Zurich Cantonal Bank
GSK icon

Zurich Cantonal Bank’s GSK GSK Stock Holding History

Zurich Cantonal Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-800
Closed -$39.2K – 2972
2025
Q4 		$39.2K Buy
+800
New +$37.3K ﹤0.01% 2448

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Zurich Cantonal Bank's GSK Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its GSK (GSK) stake by 4.1% in Q2 2026, selling an estimated $1.64K and leaving 716 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2460.

Zurich Cantonal Bank first reported a position in GSK in Q3 2021 and has held it in 17 quarters since. The position peaked at $54.1K in Q3 2025. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Zurich Cantonal Bank held 716 shares of GSK worth $37.5K as of Q2 2026.
  • Zurich Cantonal Bank sold 31 GSK shares in Q2 2026, an estimated $1.64K.
  • GSK made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2460 holding.
  • Zurich Cantonal Bank first reported a position in GSK in Q3 2021 and has held it in 17 quarters since.
  • Zurich Cantonal Bank's GSK position peaked at $54.1K in Q3 2025.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.